Lincoln Capital Corp boosted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,300 shares of the healthcare conglomerate’s stock after acquiring an additional 170 shares during the quarter. UnitedHealth Group makes up approximately 1.5% of Lincoln Capital Corp’s holdings, making the stock its 24th biggest holding. Lincoln Capital Corp’s holdings in UnitedHealth Group were worth $1,804,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Neville Rodie & Shaw Inc. raised its holdings in UnitedHealth Group by 10.5% during the second quarter. Neville Rodie & Shaw Inc. now owns 37,933 shares of the healthcare conglomerate’s stock worth $9,256,000 after purchasing an additional 3,596 shares in the last quarter. Cox Capital Mgt LLC raised its holdings in UnitedHealth Group by 4.4% during the second quarter. Cox Capital Mgt LLC now owns 8,491 shares of the healthcare conglomerate’s stock worth $2,072,000 after purchasing an additional 360 shares in the last quarter. Pensionfund DSM Netherlands raised its holdings in UnitedHealth Group by 8.0% during the second quarter. Pensionfund DSM Netherlands now owns 24,300 shares of the healthcare conglomerate’s stock worth $5,929,000 after purchasing an additional 1,800 shares in the last quarter. Pensionfund Sabic raised its holdings in UnitedHealth Group by 6.6% during the second quarter. Pensionfund Sabic now owns 16,200 shares of the healthcare conglomerate’s stock worth $3,953,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Fulton Bank N.A. increased its holdings in UnitedHealth Group by 22.8% in the second quarter. Fulton Bank N.A. now owns 7,436 shares of the healthcare conglomerate’s stock valued at $1,815,000 after buying an additional 1,382 shares in the last quarter. 85.66% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director Richard T. Burke sold 25,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total transaction of $5,914,000.00. Following the sale, the director now owns 163,331 shares in the company, valued at $38,637,581.36. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares in the company, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 33,177 shares of company stock valued at $7,842,582. Corporate insiders own 0.87% of the company’s stock.
Shares of UNH traded up $0.51 during mid-day trading on Friday, reaching $256.97. 2,161,274 shares of the company’s stock were exchanged, compared to its average volume of 4,544,972. The company has a quick ratio of 0.67, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The company has a 50-day simple moving average of $234.76 and a two-hundred day simple moving average of $241.05. UnitedHealth Group Inc has a 52-week low of $208.07 and a 52-week high of $287.94. The company has a market cap of $237.20 billion, a price-to-earnings ratio of 19.95, a PEG ratio of 1.33 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The business had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same period last year, the company posted $3.41 EPS. The company’s revenue was up 6.7% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Inc will post 14.96 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.68%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Momentum Indicators
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.